TelyRx
TelyRx is a US direct-to-consumer digital pharmacy platform connecting patients with licensed providers for non-controlled prescriptions across 450+ medications, dispensed through licensed Florida and Texas pharmacies with next-day delivery. Founded 2022, now public on TSX (TELY).
- Company typePublic
- Founded2022
- HeadquartersTampa, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What TelyRx does
TelyRx is a direct-to-consumer digital pharmacy platform that connects US patients with licensed healthcare providers to obtain non-controlled prescription medications online, bypassing traditional in-person doctor visits. Founded in 2022 and headquartered in Clearwater, Florida, the company operates an e-commerce storefront at telyrx.com where patients browse 450+ medications across therapeutic categories including chronic conditions (allergies, asthma, diabetes, hypertension, high cholesterol, thyroid), acute care (UTIs, cold/flu, infections), specialty (GLP-1 weight loss, mental health, dermatology, migraine), women's and men's health, pet medications, and prescription vitamins. Each order is reviewed by an independent network of licensed providers, typically within 24 hours, and fulfilled through licensed pharmacies in Florida and Texas with next-business-day delivery to patients across the United States.
The underlying platform is a web-based workflow integrating online consultation, provider review, prescription generation, and pharmacy fulfillment. Proprietary components include an online provider consultation platform that routes patient requests for clinical review and a pharmacy network integration connecting patients to fulfillment partners. The technology is workflow-centric rather than AI-driven; licensed clinicians vet every prescription. Compliance certifications include HIPAA, CCPA, and LegitScript, with FDA-approved medications dispensed.
TelyRx monetizes through a hybrid transaction model: a fixed $22 physician review fee per consultation plus per-unit pricing on medications (e.g., Wegovy $1,499, Ozempic $1,249, Zepbound $1,199, Rybelsus $1,149, Foundayo $799.99, generic Metformin $24.99–$27.99). No insurance or membership is required, and HSA/FSA payments are accepted. The company has cumulatively filled 1,000,000+ prescriptions. In April 2026, TelyRx completed a reverse takeover of Apolo V Acquisition Corp. and began trading on the Toronto Stock Exchange under ticker TELY, raising approximately US$36 million in concurrent private placement proceeds led by Canaccord Genuity Corp.
TelyRx firmographics
Firmographics- Name
- TelyRx
- Legal name
- TelyRx Holdings Inc.
- Website
- https://telyrx.com
- Company type
- Public
- Founded year
- 2022
- Operating status
- Ipo
- Headcount range
- 51–100 employees
- Short description
- TelyRx is a US direct-to-consumer digital pharmacy platform connecting patients with licensed providers for non-controlled prescriptions across 450+ medications, dispensed through licensed Florida and Texas pharmacies with next-day delivery. Founded 2022, now public on TSX (TELY).
- Ownership category
- akta.pro rank
TelyRx industry classification
Industry- Product category
- Online Pharmacy & Telehealth
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
- akta.pro secondary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
Keywords
Where TelyRx is headquartered
LocationHeadquarters
- HQ city
- Tampa
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
TelyRx business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Physician Review Fee: Patients pay a $22 physician review fee for provider consultation and prescription evaluation. This is a per-transaction fee charged when a patient requests medication through the platform.
- Prescription Medication Sales: Revenue generated from dispensing and delivering prescription medications to patients. Medications are fulfilled through licensed pharmacies with next business day delivery available.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Physician Review Fee |
| Unit Pricing | Pay-as-you-go | Weight Loss Medications |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
TelyRx product offering
Product offeringCore offering
TelyRx operates a direct-to-consumer digital pharmacy platform that connects US patients with licensed healthcare providers for online prescription consultations, then dispenses and delivers FDA-approved, non-controlled medications from its licensed pharmacy network in Florida and Texas. Patients pay a $22 physician review fee per consultation, select from 450+ medications across chronic, acute, lifestyle, and pet health categories, and receive next-business-day home delivery with no insurance required.
Product overview
TelyRx operates as a digital pharmacy platform providing telehealth-enabled prescription services. The core platform connects patients with licensed healthcare providers for online prescription consultations, with medications fulfilled through licensed pharmacies and delivered directly to patients. The company offers over 450 FDA-approved prescription medications across numerous therapeutic categories including chronic conditions (allergies, asthma, diabetes, hypertension, high cholesterol), acute care (cold & flu, infections), specialty conditions (weight loss, mental health, dermatology), and general health (vitamins, supplements, pet medications). The platform processes over 1 million prescriptions filled, operates with next-business-day delivery, and requires no insurance or membership—charging a $22 physician review fee. Key product categories include allergy, asthma, diabetes/weight loss, cardiovascular, migraine, dermatology, pain, women's health, men's health, mental health, thyroid, and pet medications, all accessed through a unified web portal with provider review and pharmacy fulfillment.
Differentiator
Problem solved
Functional benefit
Products and services
- Digital Pharmacy Platform Telehealth-enabled online pharmacy platform connecting US patients with licensed healthcare providers to obtain and fulfill prescriptions for FDA-approved, non-controlled medications, featuring online provider review (typically within 24 hours), prescription fulfillment, and direct-to-patient delivery.
- Pet Medications Prescription pet medications including flea/tick/heartworm prevention, motion sickness treatments, pain/anti-inflammatory medications, and skin condition remedies, delivered to pet owners through the TelyRx platform.
- Doctor's Notes & Medical Documentation Online medical documentation services including Excuse Notes for work/school and Emotional Support Animal (ESA) evaluation letters, provided through provider review without an in-person office visit.
- Continuous Glucose Monitors (CGM) Continuous glucose monitoring devices including Dexcom G6/G7 sensors and FreeStyle Libre 2/3 sensors for diabetes management, prescribed and fulfilled through the TelyRx platform.
Quantifiable outcome
- 1,000,000+ prescriptions filled
- +2 more outcomes
Companies that use TelyRx
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
TelyRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
TelyRx partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- Richard Torrez Jr.minorOlympic boxer and performance partner collaborating with TelyRx since 2024. Represents the brand as an athlete and influencer.
- Howie MandelminorComedian and actor serving as trusted partner with TelyRx since 2025. Promotes the brand through influencer marketing.
- Toni BreidingerminorRace car driver and women's health advocate partner with TelyRx since 2025. Represents the brand as a female athlete and health influencer.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
TelyRx competitors and assessment
Company assessmentDirect peers
- Hims & Hers Health: Largest publicly traded DTC telehealth and online pharmacy platform offering prescription and OTC treatments across men's health, women's health, dermatology, mental health, and weight loss on a cash-pay subscription model. Closest comparable to TelyRx in business model, catalog breadth, and target customer.
- Ro: DTC telehealth platform offering online consultations and prescription fulfillment across men's health, women's health, weight loss (GLP-1s), dermatology, and smoking cessation, with vertically integrated pharmacy. Direct competitor in the same cash-pay asynchronous prescribing model.
- Mark Cuban Cost Plus Drug Company: Online pharmacy offering transparent cash-pay pricing on prescription medications, including a growing telehealth partnership network. Competes with TelyRx on cash-pay prescription fulfillment and pricing transparency.
- GoodRx: Publicly traded platform that helps consumers compare prescription prices and access telehealth and mail-order pharmacy services, including a subscription product. Comparable in DTC cash-pay prescription access and medication price transparency.
- Sesame: DTC telehealth and prescription platform offering cash-pay online consultations and prescription fulfillment across a wide range of conditions. Direct competitor in asynchronous provider review and cash-pay pharmacy delivery.
- Lemonaid Health: DTC telehealth platform offering online provider consultations and prescription delivery for non-controlled medications across a wide range of conditions on a cash-pay basis. Direct functional peer to TelyRx, now operating under 23andMe ownership.
Broad incumbents
- Amazon Pharmacy: Amazon's online prescription fulfillment service with home delivery, integrated into Prime, offering cash-pay and insurance-based pricing. Competes with TelyRx on convenience, delivery, and price across a much broader catalog and customer base.
Emerging players
- Rex MD: DTC telehealth platform focused on men's health, particularly erectile dysfunction and hair loss, with cash-pay pricing and online provider consultations. Comparable subset of TelyRx's men's health category.
- Mochi Health: DTC telehealth provider specializing in weight loss including GLP-1 prescriptions, with cash-pay and subscription pricing. Comparable subset of TelyRx's weight loss category.
- Noom Med: Telehealth offering from Noom providing access to prescription weight loss medications including GLP-1s via online consultations. Competes in TelyRx's highest-priced product category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
TelyRx social profiles
Digital presenceTelyRx compliance and trust
Trust signalCompliance2 records
TelyRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
TelyRx leadership team
Management profileNumber of profiles
Profiles5 records
TelyRx subsidiaries and ownership
Company hierarchySubsidiaries2 records
TelyRx funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TelyRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TelyRx
What does TelyRx do?
TelyRx operates a direct-to-consumer digital pharmacy platform that connects US patients with licensed healthcare providers for online prescription consultations, then dispenses and delivers FDA-approved, non-controlled medications from its licensed pharmacy network in Florida and Texas. Patients pay a $22 physician review fee per consultation, select from 450+ medications across chronic, acute, lifestyle, and pet health categories, and receive next-business-day home delivery with no insurance required.
Is TelyRx a public or private company?
TelyRx is a public company. It is classified as public and is currently ipo.
When was TelyRx founded?
TelyRx was founded in 2022. It employs 51 to 100 people.
Where is TelyRx based?
TelyRx is headquartered in Tampa, United States, in the North America region.
How does TelyRx make money?
Two revenue lines are on record. Physician Review Fee is the primary driver. The others are prescription Medication Sales.
Who are TelyRx's main competitors?
Direct peers on record are Hims & Hers Health, Ro, Mark Cuban Cost Plus Drug Company, GoodRx, Sesame and Lemonaid Health. Amazon Pharmacy is listed as a broad incumbent. Emerging players are Rex MD, Mochi Health and Noom Med.
Does TelyRx have an API?
No public API is recorded for TelyRx.
What industry is TelyRx in?
TelyRx's product category is Online Pharmacy & Telehealth. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs). Its NAICS code is 62111 and its SIC code is 8011.